跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
the-109
首页
药物
the-109
the-109
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
US 7812218 B2
申请人: EVOGENE LTD
优先权: 2004
CN
US
9 件公开
Parvovirus formulation for treating tumors
US 10624935 B2
申请人: DEUTSCHES KREBSFORSCH
优先权: 2015
US
WO
5 件公开
Process and composition for the manufacture of a microbial-based product
US 7888062 B1
申请人: MICROBIOS INC
优先权: 2010
US
5 件公开
US 8445226 B2
申请人: GARNER MATTHEW RYAN
优先权: 2010
US
4 件公开
METHOD OF TREATING IDIOPATHIC THROMBOCYTOPENIA PURPURA (ITP) WITH ROMIPLOSTIM
EP 3720469 A1
申请人: AMGEN INC
优先权: 2017
CN
EP
US
WO
4 件公开
NEW USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A RESPIRATORY SYNCITIAL VIRUS PROTEIN AGAINST hMPV
US 2023055706 A1
申请人: UNIV PONTIFICIA CATOLICA CHILE
优先权: 2019
CN
EP
US
WO
4 件公开
Diagnostic substance and method for the analysis of metabolism processes in the brain
US 8911705 B2
申请人: ZIABREVA IRYNA
优先权: 2005
EP
US
WO
4 件公开
Method of producing a dental restoration
US 12605236 B2
申请人: IVOCLAR VIVADENT AG
优先权: 2022
CN
EP
US
4 件公开
Recombinant polypeptides having Ph1 p I epitope antigenicity and methods of diagnosing allergy in vitro
US 7148019 B2
申请人: PHADIA AB
优先权: 2001
US
4 件公开
IMMUNOGENIC FORMULATION CONTAINING A MODIFIED BCG STRAIN EXPRESSING AN ANDESVIRUS PROTEIN (ANDV) USEFUL FOR PREVENTING AND TREATING HANTA-ANDV VIRUS INFECTIONS
US 2023390378 A1
申请人: UNIV PONTIFICIA CATOLICA CHILE
优先权: 2020
CN
US
WO
3 件公开
CHROMANOL COMPOUNDS FOR TREATMENT OR PROPHYLAXIS OF AGEING-ASSOCIATED DISORDERS
EP 4486317 A1
申请人: SULFATEQ BV
优先权: 2022
CN
EP
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈